Scinai Immunotherapeutics LT
13F holders, Q2 2026 (June 30)11holders +7
7new positions
0sold out
1famous investor
$0.26avg. 13F price*
At the end of Q2 2026, 11 institutions reported holding Scinai Immunotherapeutics LT in their 13F filings, up 7 from Q1 2026. 7 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($16K), Armistice Capital, LLC ($9K) and Virtu Financial LLC ($5K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Scinai Immunotherapeutics LT
- CUSIP
- 09073Q303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $40K |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 170,385 shares bought and 7,277 shares sold, net +163,108 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Citadel Advisors | 0.00% | New | 62,257 | $16K |
| Armistice Capital, LLC | 0.00% | New | 35,942 | $9K |
| Virtu Financial LLC | 0.00% | New | 19,485 | $5K |
| StoneX Group Inc. | 0.00% | New | 13,092 | $5K |
| XTX Topco Ltd | 0.00% | Reduce -30.3% | 16,764 | $4K |
| Rhumbline Advisers | 0.00% | Add +619.5% | 13,513 | $3K |
| Captrust Financial Advisors | 0.00% | New | 12,035 | $3K |
| HRT Financial LP | 0.00% | New | 12,088 | $3K |
| UBS Group AG | 0.00% | Add +330.4% | 3,955 | $1K |
| Morgan Stanley | 0.00% | No change | 58 | $15 |
| Royal Bank of Canada | 0.00% | New | 815 | $0 |
"% of holder's portfolio" is SCINAI IMMUNOTHERAPEUTICS LT's weight in each manager's 13F, not the share of Scinai Immunotherapeutics LT the manager owns.